Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Borrega

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Journal of Clinical Medicine|February 15, 2022
COVID-19 and Intracranial Hemorrhage: A Multicenter Case Series, Systematic Review and Pooled AnalysisMoritz L Schmidbauer, Caroline Ferse, Farid Salih, et al.
Journal of Personalized Medicine|April 27, 2026
Personalizing Relapsing-Remitting Multiple Sclerosis Monitoring: Patient Acceptance of Serum Neurofilament Light Chain and the Role of Disease KnowledgeÁngel Pérez-Sempere, Elena García-Arcelay, Jacobo Caruncho Pérez, et al.
Digital Health|October 24, 2022
Study protocol of EMPOWER: A cluster randomized trial of a multimodal eHealth intervention for promoting mental health in the workplace following a stepped wedge trial designBeatriz Olaya, Christina M Van der Feltz-Cornelis, Leona Hakkaart-van Roijen, et al.
Journal of Neurology|May 1, 2020
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish populationJulia Sabin, Sarai Urtiaga, Belen Pilo, et al.
Frontiers in Psychiatry|July 23, 2025
Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosisRocío Gómez-Ballesteros, Susana Sainz de la Maza, Mónica Borges, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 15, 2023
Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approachSusana Sainz de la Maza, Rocío Gómez-Ballesteros, Mónica Borges, et al.
Multiple Sclerosis and Related Disorders|June 21, 2022
Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosisTamara Castillo-Triviño, Rocío Gómez-Ballesteros, Mónica Borges, et al.
Patient Preference and Adherence|June 20, 2023
Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple SclerosisSusana Sainz de la Maza, Jorge Maurino, Tamara Castillo-Triviño, et al.
International Journal of Molecular Sciences|June 12, 2026
Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple SclerosisLucienne Costa-Frossard, Luis Brieva, Daniel Apolinar García-Estévez, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Measuring productivity loss in early relapsing-remitting multiple sclerosisSusana Sainz de la Maza, Jorge Maurino, Mónica Borges, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Journal of Clinical Medicine|February 15, 2022
COVID-19 and Intracranial Hemorrhage: A Multicenter Case Series, Systematic Review and Pooled AnalysisMoritz L Schmidbauer, Caroline Ferse, Farid Salih, et al.
Journal of Personalized Medicine|April 27, 2026
Personalizing Relapsing-Remitting Multiple Sclerosis Monitoring: Patient Acceptance of Serum Neurofilament Light Chain and the Role of Disease KnowledgeÁngel Pérez-Sempere, Elena García-Arcelay, Jacobo Caruncho Pérez, et al.
Digital Health|October 24, 2022
Study protocol of EMPOWER: A cluster randomized trial of a multimodal eHealth intervention for promoting mental health in the workplace following a stepped wedge trial designBeatriz Olaya, Christina M Van der Feltz-Cornelis, Leona Hakkaart-van Roijen, et al.
Journal of Neurology|May 1, 2020
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish populationJulia Sabin, Sarai Urtiaga, Belen Pilo, et al.
Frontiers in Psychiatry|July 23, 2025
Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosisRocío Gómez-Ballesteros, Susana Sainz de la Maza, Mónica Borges, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 15, 2023
Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approachSusana Sainz de la Maza, Rocío Gómez-Ballesteros, Mónica Borges, et al.
Multiple Sclerosis and Related Disorders|June 21, 2022
Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosisTamara Castillo-Triviño, Rocío Gómez-Ballesteros, Mónica Borges, et al.
Patient Preference and Adherence|June 20, 2023
Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple SclerosisSusana Sainz de la Maza, Jorge Maurino, Tamara Castillo-Triviño, et al.
International Journal of Molecular Sciences|June 12, 2026
Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple SclerosisLucienne Costa-Frossard, Luis Brieva, Daniel Apolinar García-Estévez, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Measuring productivity loss in early relapsing-remitting multiple sclerosisSusana Sainz de la Maza, Jorge Maurino, Mónica Borges, et al.
Pageof 15